Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-19-026250
Filing Date
2019-07-26
Accepted
2019-07-26 08:05:26
Documents
12
Period of Report
2019-09-05
Effectiveness Date
2019-07-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A onvo-def14a_20190905.htm DEF 14A 1547668
2 GRAPHIC gmvh5f2d3knk000003.jpg GRAPHIC 3102
3 GRAPHIC gmvh5f2d3knk000010.jpg GRAPHIC 49206
4 GRAPHIC gmvh5f2d3knk000011.jpg GRAPHIC 37954
5 GRAPHIC gmvh5f2d3knk000001.jpg GRAPHIC 2762
6 GRAPHIC gmvh5f2d3knk000005.jpg GRAPHIC 12661
7 GRAPHIC gmvh5f2d3knk000002.jpg GRAPHIC 3102
8 GRAPHIC gmvh5f2d3knk000006.jpg GRAPHIC 10370
9 GRAPHIC gmvh5f2d3knk000004.jpg GRAPHIC 2762
10 GRAPHIC gmvh5f2d3knk000008.jpg GRAPHIC 10773
11 GRAPHIC gmvh5f2d3knk000007.jpg GRAPHIC 12542
12 GRAPHIC gmvh5f2d3knk000009.jpg GRAPHIC 3102
  Complete submission text file 0001564590-19-026250.txt   1754834
Mailing Address 6275 NANCY RIDGE DRIVE SUITE 110 SAN DIEGO CA 92121
Business Address 6275 NANCY RIDGE DRIVE SUITE 110 SAN DIEGO CA 92121 858-224-1000
ORGANOVO HOLDINGS, INC. (Filer) CIK: 0001497253 (see all company filings)

EIN.: 271488943 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-35996 | Film No.: 19975952
SIC: 2836 Biological Products, (No Diagnostic Substances)